A multicountry pooled analysis shows that treatment success rates for extensively drug-resistant tuberculosis are extremely ...

In Germany, it is often overlooked that diseases once thought to be defeated, like tuberculosis, still exist and that the ...

Your healthcare provider may also recommend a TB test — either a blood test or a skin test. For the skin test, you will need ...

TB infection is different from active TB disease; and a flare up could happen within weeks of acquiring the infection or maybe years ...

Tuberculosis (TB) belongs to infectious diseases leading to the high mortality and morbidity worldwide. Since long-term ...

A recent phase 2b clinical trial in South Africa found that Bacille Calmette-Guérin (BCG) revaccination did not prevent ...

High-dose rifampicin may clear TB bacteria faster, but risks like liver injury above 30 mg/kg need caution. Larger trials are ...

A vaccine protects more than 100 million infants each year from severe tuberculosis (TB), including the fatal brain swelling it can cause in babies and toddlers.

Current treatment for bedaquiline-resistant tuberculosis is linked with poor microbiological responses, unfavorable clinical ...

First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively ...

Differentiated TB care involves tailoring services to individual needs of patients. Researchers pitch it as a model that can ...

TB can be cured, but ridding the body of the bug often takes many months and usually requires taking four or more different medicines. In this Spotlight special briefing, we zoom in on what makes the ...